Tag:

Bionor

Latest Headlines

Latest Headlines

HIV therapeutic vaccine shows promise

January 3, 2013 | By
As a new wave of interest in HIV therapeutic vaccines hits the biotech world, a team of Spanish researchers claims to have developed such a vaccine that temporarily halts growth of the HIV virus in patients.

Combating HIV: The future of therapeutic vaccines

December 13, 2012 | By
HIV patients rely on a bevy of drugs to keep their illness under control, sticking to a strict regimen to maintain health. But let's face it: Adherence is a challenge and drug side effects can be rough. Enter HIV therapeutic vaccines. Read more >>

Norway's Bionor snags $1.7 million for HIV vaccine research

July 10, 2012 | By
Norway's Bionor Pharma landed $1.7 million from the Research Council of Norway's Globvac program to learn more about what role a vaccine can play in eliminating HIV.

Bionor's new HIV vaccine moves into clinical trials

May 31, 2012 | By
Bionor's latest HIV vaccine, Vacc-C5, is ready to go into therapeutic clinical trials at Oslo University Hospital.

Nasal HIV vax safe, triggers immune response

May 17, 2012 | By
The therapeutic HIV vaccine that the company nearly shelved in October 2011, Bionor's Vacc-4X, was safe given nasally to HIV-positive patients also on antiretrovirals.

Bionor HIV vaccine lowers viral load, ART need

September 14, 2011 | By
Norwegian biotech Bionor Pharma has released results from a study of its therapeutic HIV vaccine, Vacc-4x. After initially planning to shelve the vaccine last October, the company is now plotting
Related Tags
Press Releases
  • Philips Volcano announces more than 5,000 Coronary Artery Disease patients enrolled in iFR Outcomes Trials
  • Sun Pharma enters Japanese prescription market
  • Veracyte Secures Up to $45 Million in Financing from Visium Healthcare Partners
  • Merck Statement on hep C verdict
  • Quanterix Raises $46 Million in Series D Financing
  • More Press Releases
Sponsored Links